FGFR3 and urinary bladder cancer: This is best highlighted with the switch from the FGFR3-IIIb isoform to the oncogenic FGFR3-IIIc isoform; this alternative splicing event has been shown to promote invasiveness in prostate and bladder cancers [26,27].